ChemoCentryx, Inc.
CCXI · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$131,755 | -$55,356 | -$55,489 | -$37,966 |
| Dep. & Amort. | $3,139 | $797 | $1,642 | $512 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $30,692 | $22,912 | $11,638 | $10,833 |
| Change in WC | $16,371 | -$52,956 | -$26,415 | $44,128 |
| Other Non-Cash | $5,932 | $3,460 | -$1,499 | -$1,071 |
| Operating Cash Flow | -$75,621 | -$81,143 | -$70,123 | $16,436 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$19,020 | -$15,409 | -$790 | -$838 |
| Net Acquisitions | -$92,219 | $0 | $0 | $0 |
| Inv. Purchases | -$307,449 | -$445,671 | -$211,973 | -$192,480 |
| Inv. Sales/Matur. | $418,688 | $178,720 | $200,237 | $140,250 |
| Other Inv. Act. | $92,219 | $0 | $0 | $0 |
| Investing Cash Flow | $92,219 | -$282,360 | -$12,526 | -$53,068 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $7,405 | $325,654 | $73,276 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,083 | $356,621 | $94,820 | $24,700 |
| Financing Cash Flow | $1,083 | $356,621 | $94,820 | $24,700 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $17,681 | -$6,882 | $12,171 | -$11,932 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $33,377 | $40,259 | $28,088 | $40,020 |
| End Cash | $51,058 | $33,377 | $40,259 | $28,088 |
| Free Cash Flow | -$94,641 | -$96,552 | -$70,913 | $15,598 |